about
ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancerChemT, an open-source software for building template-based chemical libraries.MOLA: a bootable, self-configuring system for virtual screening using AutoDock4/Vina on computer clusters.Antioxidants in wild mushrooms.New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death.Aminodi(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, effects in human tumor cells growth, cell cycle analysis, apoptosis and evaluation of toxicity using non-tumor cells.1-aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR-2 tyrosine kinase inhibitors: synthesis, biological evaluation, and molecular modelling studies.A QCAR model for predicting antioxidant activity of wild mushrooms.Antiangiogenic compounds: well-established drugs versus emerging natural molecules.Using molecular docking to investigate the anti-breast cancer activity of low molecular weight compounds present on wild mushrooms.Molecular motion regulates the activity of the Mitochondrial Serine Protease HtrA2.Apoptosis induction by Pleurotus sajor-caju (Fr.) Singer extracts on colorectal cancer cell lines.Wild Roman chamomile extracts and phenolic compounds: enzymatic assays and molecular modelling studies with VEGFR-2 tyrosine kinase.Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors.Selective flexibility of side-chain residues improves VEGFR-2 docking score using AutoDock Vina.Docking Studies in Target Proteins Involved in Antibacterial Action Mechanisms: Extending the Knowledge on Standard Antibiotics to Antimicrobial Mushroom CompoundsCrataegus monogyna buds and fruits phenolic extracts: Growth inhibitory activity on human tumor cell lines and chemical characterization by HPLC–DAD–ESI/MSInsights in the antioxidant activity of diarylamines from the 2,3-dimethylbenzo[b]thiophene through the redox profileQCAR models to predict wild mushrooms radical scavenging activity, reducing power and lipid peroxidation inhibitionCalluna vulgaris (L.) Hull: chemical characterization, evaluation of its bioactive properties and effect on the vaginal microbiotaJabuticaba residues (Myrciaria jaboticaba (Vell.) Berg) are rich sources of valuable compounds with bioactive propertiesBiological Activities Evaluation of Enantiopure Isoxazolidine Derivatives: In Vitro, In Vivo and In Silico StudiesNutritional, chemical and bioactive profiles of different parts of a Portuguese common fig (Ficus carica L.) varietyPhytochemical profile and biological activities of 'Ora-pro-nobis' leaves (Pereskia aculeata Miller), an underexploited superfood from the Brazilian Atlantic Forest
P50
Q24810389-94CC1754-1BE4-4C9A-B5A9-51BEFB1697F8Q33993994-49CD3A89-F5A1-4C54-8237-4886F4F8D864Q34331455-481FC148-6CFB-4F76-8B7F-C86CB9A122D7Q37438162-114CA429-A173-40F1-955F-96A7DFA12068Q39079845-F22C31FD-1397-414E-9A0A-09166AC00294Q39372668-ADE7F831-AB49-48CE-BFEC-F9E2889D32E0Q41851477-82465347-78D9-4F5E-B92E-1121163FF0DDQ43241580-4A5CDE91-48EA-4D5A-8E8E-6C35F9D84976Q47267388-B1380B6F-1F6C-456D-9B8F-05FA557B74FFQ47375702-A3AE5CF1-A7A3-49CB-B2CC-19E358ACBDC0Q48204841-AD831B22-2E6B-4136-A3CC-CB230717B422Q50032811-39696B97-3C15-4392-B521-1B1C2CAEACB8Q52911526-7905DDD5-FB47-4F99-A267-356ED1A73886Q53211616-7A3B90C9-A4FD-45E2-8C95-ED3918B03F7DQ54248034-5C193DC4-3AE8-4D0A-8E56-583F852DFF48Q54541635-5111C232-3E66-4E36-9B88-98CE34365238Q57757644-7F4AEC0E-5ED5-4A8B-8788-BEA717941198Q58308446-F466A6F2-8148-4642-A23A-70A84D4AD916Q58308485-84DD3C48-36DF-4E3F-980A-27FD6F3CFACEQ61875770-2D97D0E1-A055-40DC-B5CE-DCA8A6B063E5Q90418347-F60B3137-F580-4454-8DA8-7157E0900010Q91194270-225BF368-A849-482E-AF8E-F10F89067CFDQ91244106-7D1F3AC5-D462-4DEE-B8B8-FAA015469808Q91300692-3CA4F6F7-670A-416F-AD69-1A8B8188C412Q92278189-9252C338-EDAA-4418-AEBE-86C2B6BB492F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rui Abreu
@ast
Rui Abreu
@en
Rui Abreu
@es
Rui Abreu
@nl
type
label
Rui Abreu
@ast
Rui Abreu
@en
Rui Abreu
@es
Rui Abreu
@nl
prefLabel
Rui Abreu
@ast
Rui Abreu
@en
Rui Abreu
@es
Rui Abreu
@nl
P106
P1153
7003290613
P31
P496
0000-0002-7745-8015